Interaction of stable colloidal nanoparticles with cellular membranes

Biotechnology Advances

Volumn 32, Issue 4, 2014, Pages 679-692

  Mahmoudi, Morteza ^a   Meng, Jie ^b   Xue, Xue ^b   Liang, Xing Jie ^b   Rahman, Masoud ^c   Pfeiffer, Christian ^d   Hartmann, Raimo ^d   Gil, Pilar Rivera ^d   Pelaz, Beatriz ^d   Parak, Wolfgang J ^d,e   Del Pino, Pablo ^d,e   Carregal Romero, Susana ^d,f   Kanaras, Antonios G ^g   Tamil Selvan, Subramanian ^h,i  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^c University of California Davis   (United States)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e CIC BIOMAGUNE   (Spain)

^f Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h INSTITUTE OF MATERIALS RESEARCH AND ENGINEERING   (Singapore)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cell membrane; Colloid; Nanoparticle; Protein corona; Receptor; Targeted delivery

Indexed keywords

COLLOIDS; CYTOLOGY; DRUG DELIVERY; NANOPARTICLES;

BIOLOGICAL ENVIRONMENTS; BIOMEDICAL SCIENCE; COLLOIDAL NANOPARTICLES; INORGANIC NANOPARTICLE; PROTEIN CORONAS; RECEPTOR; TARGETED DELIVERY; TARGETED DRUG DELIVERY;

CELL MEMBRANES;

BIOTECHNOLOGY; COLLOID; DISEASE TREATMENT; DRUG; EUKARYOTE; MEMBRANE; NANOTECHNOLOGY; PROTEIN;

EUKARYOTA;

COLLOID; NANOPARTICLE; PROTEIN;

ANIMAL; BLOOD BRAIN BARRIER; CELL MEMBRANE; CELL STRUCTURE; CHEMISTRY; COLLOID; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FEVER; GENE THERAPY; GENETIC PROCEDURES; HUMAN; METABOLISM; NANOMEDICINE; NANOTECHNOLOGY; PROCEDURES; SURFACE PROPERTY;

ANIMALS; BIOSENSING TECHNIQUES; BLOOD-BRAIN BARRIER; CELL MEMBRANE; CELLULAR STRUCTURES; COLLOIDS; DRUG DELIVERY SYSTEMS; FEVER; GENETIC THERAPY; HUMANS; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; PROTEINS; SURFACE PROPERTIES;

EID: 84902000110     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2013.11.012     Document Type: Review

References (219)

1. Albanese A., Chan W.C.W. Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano 2011, 5:5478-5489.
2. Al-Jamal W.T., Kostarelos K. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc. Chem. Res. 2011, 44:1094-1104.
3. Alkilany A.M., Nagaria P.K., Hexel C.R., Shaw T.J., Murphy C.J., Wyatt M.D. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small 2009, 5:701-708.
4. Anitei M., Hoflack B. Bridging membrane and cytoskeleton dynamics in the secretory and endocytic pathways. Nat. Cell Biol. 2012, 14:11-19.
5. Asati A., Santra S., Kaittanis C., Perez J.M. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano 2010, 4:5321-5331.
6. Ba H.J., Rodríguez-Fernández J., Stefani F.D., Feldmann J. Immobilization of gold nanoparticles on living cell membranes upon controlled lipid binding. Nano Lett. 2010, 10:3006-3012.
7. Bao G., Bao X.R. Shedding light on the dynamics of endocytosis and viral budding. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9997-9998.
8. Bardhan R., Chen W., Perez-Torres C., Bartels M., Huschka R.M., Zhao L.L., et al. Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response. Adv. Funct. Mater. 2009, 19:3901-3909.
9. Bartczak D., Kanaras A.G. Diacetylene-containing ligand as a new capping agent for the preparation of water-soluble colloidal nanoparticles of remarkable stability. Langmuir 2010, 26:7072-7077.
10. Bartczak D., Kanaras A. Preparation of peptide-functionalized gold nanoparticles using one pot EDC/sulfo-NHS coupling. Langmuir 2011, 27:10119-10123.
11. Bartczak D., Muskens O.L., Millar T.M., Sanchez-Elsner T., Kanaras A.G. Laser-induced damage and recovery of plasmonically targeted human endothelial cells. Nano Lett. 2011, 11:1358-1363.
12. Bartczak D., Sanchez-Elsner T., Louafi F., Millar T.M., Kanaras A.G. Receptor-mediated interactions between colloidal gold nanoparticles and human umbilical vein endothelial cells. Small 2011, 7:388-394.
13. Bartczak D., Muskens O.L., Nitti S., Sanchez-Elsner T., Millar T.M., Kanaras A.G. Interactions of human endothelial cells with gold nanoparticles of different morphologies. Small 2012, 8:122-130.
14. Bartczak D., Nitti S., Millar T.M., Kanaras A.G. Exocytosis of peptide functionalized gold nanoparticles in endothelial cells. Nanoscale 2012, 4:4470-4472.
15. Bhabra G., Sood A., Fisher B., Cartwright L., Saunders M., Evans W.H., et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat. Nanotechnol. 2009, 4:876-883.
16. Bhaskar S., Tian F.R., Stoeger T., Kreyling W., de la Fuente J.M., Grazu V., et al. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part. Fibre Toxicol. 2010, 7:3.
17. Bhirde A.A., Patel V., Gavard J., Zhang G., Sousa A.A., Masedunskas A., et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009, 3:307-316.
18. Bianco A., Kostarelos K., Prato M. Applications of carbon nanotubes in drug delivery. Curr. Opin. Chem. Biol. 2005, 9:674-679.
19. Bretscher M.S. Membrane structure: some general principles. Science 1973, 181:622-629.
20. Bringas E., Koysuren O., Quach D.V., Mahmoudi M., Aznar E., Roehling J.D., et al. Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field. Chem. Commun. 2012, 48:5647-5649.
21. Buono C., Anzinger J.J., Amar M., Kruth H.S. Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions. J. Clin. Invest. 2009, 119:1373-1381.
22. Burgess B.L., Cavigiolio G., Fannucchi M.V., Illek B., Forte T.M., Oda M.N. A phospholipid-apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective properties. Int. J. Pharm. 2010, 399:148-155.
23. Cai D., Mataraza J.M., Qin Z.H., Huang Z., Huang J., Chiles T.C., et al. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat. Methods 2005, 2:449-454.
24. Candeloro P., Tirinato L., Malara N., Fregola A., Casals E., Puntes V., et al. Nanoparticle microinjection and Raman spectroscopy as tools for nanotoxicology studies. Analyst 2011, 136:4402-4408.
25. Canton I., Battaglia G. Endocytosis at the nanoscale. Chem. Soc. Rev. 2012, 41:2718-2739.
26. Caswell P., Norman J. Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol. 2008, 18:257-263.
27. Chakraborty S.K., Fitzpatrick J.A.J., Phillippi J.A., Andreko S., Waggoner A.S., Bruchez M.P., et al. Cholera Toxin B conjugated quantum dots for live cell labeling. Nano Lett. 2007, 7:2618-2626.
28. Chan W.C.W., Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998, 281:2016-2018.
29. Chaudhary S., Smith C., del Pino P., de la Fuente J., Mullin M., Hursthouse A., et al. Elucidating the function of penetratin and a static magnetic field in cellular uptake of magnetic nanoparticles. Pharmaceuticals 2013, 6:204-222.
30. Chen X., Kis A., Zettl A., Bertozzi C.R. A cell nanoinjector based on carbon nanotubes. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:8218-8222.
31. Cheng S., Levy D. The effects of cell proliferation on the lipid composition and fluidity of hepatocyte plasma membranes. Arch. Biochem. Biophys. 1979, 196:424-429.
32. Child H.W., Del Pino P.A., De La Fuente J.M., Hursthouse A.S., Stirling D., Mullen M., et al. Working together: the combined application of a magnetic field and penetratin for the delivery of magnetic nanoparticles to cells in 3D. ACS Nano 2011, 5:7910-7919.
33. Chithrani D.B. Intracellular uptake, transport, and processing of gold nanostructures. Mol. Membr. Biol. 2010, 27:299-311.
34. Chithrani B.D., Chan W.C.W. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7:1542-1550.
35. Chithrani B.D., Ghazan A.A., Chan C.W. Determining the size and the shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006, 6:662-668.
36. Cho E.C., Au L., Zhang Q., Xia Y. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small 2010, 6:517-522.
37. Cho E.C., Zhang Q., Xia Y.N. The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat. Nanotechnol. 2011, 6:385-391.
38. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., et al. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25:1165-1170.
39. Choi C.H.J., Zuckerman J.E., Webster P., Davis M.E. Targeting kidney mesangium by nanoparticles of defined size. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6656-6661.
40. Chou L.Y., Ming K., Chan W.C. Strategies for the intracellular delivery of nanoparticles. Chem. Soc. Rev. 2011, 40:233-245.
41. Conde J., Ambrosone A., Sanz V., Hernandez Y., Marchesano V., Tian F., et al. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano 2012, 6:8316-8324.
42. Cortie M.B., McDonagh A.M. Synthesis and optical properties of hybrid and alloy plasmonic nanoparticles. Chem. Rev. 2011, 111:3713-3735.
43. Cross T.A., Sharma M., Yi M., Zhou H.X. Influence of solubilizing environments on membrane protein structures. Trends Biochem. Sci. 2011, 36:117-125.
44. Cutler J.I., Auyeung E., Mirkin C.A. Spherical nucleic acids. J. Am. Chem. Soc. 2012, 134:1376-1391.
45. Dahan M., Laurence T., Pinaud F., Chemla D.S., Alivisatos A.P., Sauer M., et al. Time-gated biological imaging by use of colloidal quantum dots. Opt. Lett. 2001, 26:825-827.
46. Daley D.O. The assembly of membrane proteins into complexes. Curr. Opin. Struct. Biol. 2008, 18:420-424.
47. Dang S.P., Wang R.X., Qin M.D., Zhang Y., Gu Y.Z., Wang M.Y., et al. A novel transfection method for eukaryotic cells using polyethylenimine coated albumin microbubbles. Plasmid 2011, 66:19-25.
48. Davis M.E., Zuckerman J.E., Choi C.H.J., Seligson D., Tolcher A., Alabi C.A., et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464:1067-1070.
49. Dawson K.A. Leave the policing to others. Nat. Nanotechnol. 2013, 8:73.
50. Day H.A., Bartczak D., Fairbairn N., Mcguire E., Ardakani M., Porter A.E., et al. Controlling the three-dimensional morphology of nanocrystals. CrystEngComm 2010, 12:4312-4316.
51. de Bruin K.G., Fella C., Ogris M., Wagner E., Ruthardt N., Brauchle C. Dynamics of photoinduced endosomal release of polyplexes. J. Control. Release 2008, 130:175-182.
52. de la Fuente J.M., Berry C.C. Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. Bioconjug. Chem. 2005, 16:1176-1180.
53. Decuzzi P., Ferrari M. The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials 2007, 28:2915-2922.
54. Dejardin T., de la Fuente J., del Pino P., Furlani E.P., Mullin M., Smith C.A., et al. Influence of both a static magnetic field and penetratin on magnetic nanoparticle delivery into fibroblasts. Nanomedicine 2011, 6:1719-1731.
55. del Pino P., Munoz-Javier A., Vlaskou D., Rivera Gil P., Plank C., Parak W.J. Gene silencing mediated by magnetic lipospheres tagged with small interfering RNA. Nano Lett. 2010, 10:3914-3921.
56. del Pino P., Pelaz B., Zhang Q., Maffre P., Nienhaus U., Parak W.J. Protein corona formation around nanoparticles -from the past to the future. Mater. Horiz. 2013, 10.1039/C3MH00106G.
57. Deng Z.J., Liang M., Monteiro M., Toth I., Minchin R.F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol. 2011, 6:39-44.
58. Derfus A.M., Chan W.C.W., Bhatia S.N. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv. Mater. 2004, 16:961-966.
59. Deserno M. When do fluid membranes engulf sticky colloids?. J. Phys. Condens. Matter 2004, 16:1-10.
60. Deserno M., Gelbart W.M. Adhesion and wrapping in colloid-vesicle complexes. J. Phys. Chem. B 2002, 106:5543-5552.
61. Di Corato R., Palumberi D., Marotta R., Scotto M., Carregal-Romero S., Rivera_Gil P., et al. Magnetic nanobeads decorated with silver nanoparticles as cytotoxic agents and photothermal probes. Small 2012, 8:2731-2742.
62. Dickerson E.B., Dreaden E.C., Huang X., El-Sayed I.H., Chu H., Pushpanketh S., et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008, 269:57-66.
63. Doane T.L., Cheng Y., Babar A., Hill R.J., Burda C. Electrophoretic mobilities of PEGylated gold NPs. J. Am. Chem. Soc. 2010, 132:15624-15631.
64. Dubavik A., Sezgin E., Lesnyak V., Gaponik N., Schwille P., Eychmüller A. Penetration of amphiphilic quantum dots through model and cellular plasma membranes. ACS Nano 2012, 6:2150-2156.
65. Dustin M.L., Long E.O. Cytotoxic immunological synapses. Immunol. Rev. 2010, 235:24-34.
66. Farokhzad O.C., Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3:16-20.
67. 2 sensing probe based on cell-penetrating phosphorescent nanoparticles. ACS Nano 2011, 5:5499-5508.
68. Fernandez Cabada T., de Pablo C.S., Serrano A.M., Guerrero Fdel P., Olmedo J.J., Gomez M.R. Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods. Int. J. Nanomedicine 2012, 7:1511-1523.
69. Fischer H.C., Chan W.C.W. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotechnol. 2007, 18:565-571.
70. Gazeau F., Lévy M., Wilhelm C. Optimizing magnetic nanoparticle design for nanothermotherapy. Nanomedicine 2008, 3:831-844.
71. Ghavami M., Saffar S., Abd Emamy B., Peirovi A., Shokrgozar M.A., Serpooshan V., et al. Plasma concentration gradient influences the protein corona decoration on nanoparticles. RSC Adv. 2013, 3:1119-1126.
72. Goesmann H., Feldmann C. Nanoparticulate functional materials. Angew. Chem. Int. Ed. 2010, 49:1362-1395.
73. Goldstein J.L., Anderson R.G., Brown M.S. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 1979, 279:679-685.
74. Goodman C.M., McCusker C.D., Yilmaz T., Rotello V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem. 2004, 15:897-900.
75. Gordon R.T., Hines J.R., Gordon D. Intracellular hyperthermia a biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med. Hypotheses 1979, 5:83-102.
76. Gu Y., Sun W., Wang G., Fang N. Single particle orientation and rotation tracking discloses distinctive rotational dynamics of drug delivery vectors on live cell membranes. J. Am. Chem. Soc. 2011, 133:5720-5723.
77. Gulaya N.M., Volkov G.L., Klimashevsky V.M., Govseeva N.N., Melnik A.A. Changes in lipid composition of neuroblastoma C1300 N18 cell during differentiation. Neuroscience 1989, 30:153-164.
78. Hak S., Helgesen E., Hektoen H.H., Huuse E.M., Jarzyna P.A., Mulder W.J.M., et al. The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging. ACS Nano 2012, 6:5648-5658.
79. Hatakeyama H., Akita H., Harashima H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv. Drug Deliv. Rev. 2011, 63:152-160.
80. Hilder T.A., Hill J.M. Carbon nanotubes as drug delivery nanocapsules. Curr. Appl. Phys. 2008, 8:258-261.
81. Hine R. The Facts on File Dictionary of Biology 1999, Facts On File, New York.
82. Hofinger S., Melle-Franco M., Gallo T., Cantelli A., Calvaresi M., Gomes J.A., et al. A computational analysis of the insertion of carbon nanotubes into cellular membranes. Biomaterials 2011, 32:7079-7085.
83. Hom C., Lu J., Liong M., Luo H., Li Z., Zink J.I., et al. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. Small 2010, 6:1185-1190.
84. Howard K.A. Delivery of RNA interference therapeutics using polycation-based nanoparticles. Adv. Drug Deliv. Rev. 2009, 61:710-720.
85. Huang X., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 2006, 128:2115-2120.
86. Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 2008, 23:217-228.
87. Hühn D., Kantner K., Geidel C., Brandholt S., De Cock I., Soenen S.J.H., et al. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano 2013, 7:3253-3263.
88. Ibanez M., Zamani R., Li W.H., Shavel A., Arbiol J., Morante J.R., et al. Extending the nanocrystal synthesis control to quaternary compositions. Cryst. Growth Des. 2012, 12:1085-1090.
89. Jewell C.M., Jung J.M., Atukorale P.U., Carney R.P., Stellacci F., Irvine D.J. Oligonucleotide delivery by cell-penetrating "striped" nanoparticles. Angew. Chem. Int. Ed. 2011, 50:12312-12315.
90. Jiang W., Kim B.Y.S., Rutka J.T., Chan W.C.W. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 2008, 3:145-150.
91. Jin H., Heller D.A., Strano M.S. Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubes in NIH-3T3 cells. Nano Lett. 2008, 8:1577-1585.
92. Jin H., Heller D.A., Sharma R., Strano M.S. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 2009, 3:149-158.
93. Jordan A., Wust P., Fahling H., John W., Hinz A., Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int. J. Hyperthermia 1993, 9:51-68.
94. Jordan A., Scholz R., Maier-Hauff K., van Landeghem F.K.H., Waldoefner N., Teichgraeber U., et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J. Neurooncol 2006, 78:7-14.
95. Josephson L., Tung C.-H., Moore A., Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 1999, 10:186-191.
96. Kam N.W., Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J. Am. Chem. Soc. 2005, 127:6021-6026.
97. Kanaras A.G., Kamounah F.S., Schaumburg K., Kiely C.J., Brust M. Thioalkylated tetraethylene glycol: a new ligand for water soluble monolayer protected gold clusters. Chem. Commun. 2002, 2002:2294-2295.
98. Kievit F.M., Veiseh O., Bhattarai N., Fang C., Gunn J.W., Lee D., et al. PEI-PEG-chitosan-copolymer-coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection. Adv. Funct. Mater. 2009, 19:2244-2251.
99. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed. 2008, 120:8566-8569.
100. Kim B., Han G., Toley B.J., Kim C.K., Rotello V.M., Forbes N.S. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat. Nanotechnol. 2010, 5:465-472.
101. Kong G., Braun R.D., Dewhirst M.W. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res. 2000, 60:4440-4445.
102. Krol S., Macrez R., Docagne F., Defer G., Laurent S., Rahman M., et al. Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. Chem. Rev. 2012, 113:1877-1903.
103. Krug H.F., Wick P. Nanotoxicology: an interdisciplinary challenge. Angew. Chem. Int. Ed. 2011, 50:1260-1278.
104. Kuo C.-W., Chueh D.-Y., Singh N., Chien F.-C., Chen P. Targeted nuclear delivery using peptide-coated quantum dots. Bioconjug. Chem. 2011, 22:1073-1080.
105. Laurent S., Mahmoudi M. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet. 2011, 2:367-390.
106. Laurent S., Dutz S., Häfeli U.O., Mahmoudi M. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv. Colloid Interface Sci. 2011, 166:8-23.
107. Laurent S., Burtea C., Thirifays C., Häfeli U.O., Mahmoudi M. Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications and "cell vision". PLoS ONE 2012, 7:e29997.
108. Laurent S., Burtea C., Thirifays C., Rezaee F., Mahmoudi M. Significance of cell "observer" and protein source in nanobiosciences. J. Colloid Interface Sci. 2013, 392:431-445.
109. Lee J., Sharei A., Sim W.Y., Adamo A., Langer R., Jensen K.F., et al. Nonendocytic delivery of functional engineered nanoparticles into the cytoplasm of live cells using a novel, high-throughput microfluidic device. Nano Lett. 2012, 12:6322-6327.
110. Lesniak A., Salvati A., Santos-Martinez M.J., Radomski M.W., Dawson K.A., Åberg C. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J. Am. Chem. Soc. 2013, 135:1438-1444.
111. 3 nanoparticles. J. Phys. Condens. Matter 2008, 20:204133.
112. Lévy M., Quarta A., Espinosa A., Figuerola A., Wilhelm C., García-Hernández M., et al. Correlating magneto-structural properties to hyperthermia performance of highly monodisperse iron oxide nanoparticles prepared by a seeded-growth route. Chem. Mater. 2011, 23:4170-4180.
113. Lewis B.A., Engelman D.M. Lipid bilayer thickness varies linearly with acyl chain length in fluid phosphatidylcholine vesicles. J. Mol. Biol. 1983, 166:211-217.
114. Li Y., Li X., Li Z., Gao H. Surface-structure-regulated penetration of nanoparticles across a cell membrane. Nanoscale 2012, 4:3768.
115. Lin J.Q., Chen R., Feng S.Y., Li Y.Z., Huang Z.F., Xie S.S., et al. Rapid delivery of silver nanoparticles into living cells by electroporation for surface-enhanced Raman spectroscopy. Biosens. Bioelectron. 2009, 25:388-394.
116. Lin J., Zhang H., Chen Z., Zheng Y. Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship. ACS Nano 2010, 4:5421-5429.
117. Liu W., Howarth M., Greytak A.B., Zheng Y., Nocera D.G., Ting A.Y., et al. Compact biocompatible quantum dots functionalized for cellular imaging. J. Am. Chem. Soc. 2008, 130:1274-1284.
118. Liu M., Chen B., Xue Y., Huang J., Zhang L., Huang S., et al. Polyamidoamine-grafted multiwalled carbon nanotubes for gene delivery: synthesis, transfection and intracellular trafficking. Bioconjug. Chem. 2011, 22:2237-2243.
119. Luccardini C., Yakovlev A., Gaillard S., Mvt Hoff, Alberola A.P., Mallet J.-M., et al. Getting across the plasma membrane and beyond: intracellular uses of colloidal semiconductor nanocrystals. J Biomed Biotechnol 2007, 2007. [Article ID 68963].
120. Luo J.T., Xiao K., Li Y.P., Lee J.S., Xiao W.W., Gonik A.M., et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 2011, 32:3435-3446.
121. Mahmoudi M., Shokrgozar M.A. Multifunctional stable fluorescent magnetic nanoparticles. Chem. Commun. 2012, 48:3957-3959.
122. Mahmoudi M., Lynch I., Ejtehadi M.R., Monopoli M.P., Bombelli F.B., Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem. Rev. 2011, 111:5610-5637.
123. Mahmoudi M., Amiri H., Shokrgozar M.A., Sasanpour P., Rashidian B., Laurent S., et al. Raman active jagged-shaped gold-coated magnetic particles as a novel multimodal nanoprobe. Chem. Commun. 2011, 47:10404-10406.
124. Mahmoudi M., Azadmanesh K., Shokrgozar M.A., Journeay W.S., Laurent S. Effect of nanoparticles on the cell life cycle. Chem. Rev. 2011, 111:3407-3432.
125. Mahmoudi M., Hofmann H., Rothen-Rutishauser B., Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem. Rev. 2011, 112:2323-2338.
126. Mahmoudi M., Laurent S., Shokrgozar M.A., Hosseinkhani M. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles. ACS Nano 2011, 5:7263-7276.
127. Mahmoudi M., Saeedi-Eslami S.N., Shokrgozar M.A., Azadmanesh K., Hassanlou M., Kalhor H.R., et al. Cell "vision": complementary factor of protein corona in nanotoxicology. Nanoscale 2012, 4:5461-5468.
128. Mahmoudi M., Bonakdar S., Shokrgozar M.A., Aghaverdi H., Hartmann R., Pick A., et al. ACS Nano 2013, 7:8379-8384.
129. Mahmoudi M., Dutz S., Behzadi S., Ejtehadi M.R., Rezaei M., Shokrgozar M.A., et al. Temperature -the ignored factor at the nanobio interface. ACS Nano 2013, 7:6555-6562.
130. Mailander V., Landfester K. Interaction of nanoparticles with cells. Biomacromolecules 2009, 10:2379-2400.
131. Meng H., Liong M., Xia T., Li Z., Ji Z., Zink J.I., et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and p-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010, 4:4539-4550.
132. Meng H., Mai W.X., Zhang H., Xue M., Xia T., Lin S., et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano 2013, 7:994-1005.
133. Milani S., Baldelli Bombelli F., Pitek A.S., Dawson K.A., Rädler J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano 2012, 6:2532-2541.
134. Mirshafiee V., Mahmoudi M., Lou K., Cheng J., Kraft M.L. Protein corona significantly reduces active targeting yield. Chem. Commun. 2013, 49:2557-2559.
135. Mitra K., Ubarretxena-Belandia I., Taguchi T., Warren G., Engelman D.M. Modulation of the bilayer thickness of exocytic pathway membranes by membrane proteins rather than cholesterol. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4083-4088.
136. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J. 2005, 19:311-330.
137. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Baldelli Bombelli F., et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133:2525-2534.
138. Moros M., Hernáez B., Garet E., Dias J.T., Sáez B., Grazú V., et al. Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake. ACS Nano 2012, 6:1565-1577.
139. Muñoz Javier A., Kreft O., Piera Alberola A., Kirchner C., Zebli B., Susha A.S., et al. Combined atomic force microscopy and optical microscopy measurements as a method to investigate particle uptake by cells. Small 2006, 2:394-400.
140. Mykhaylyk O., Sobisch T., Almstätter I., Sanchez-Antequera Y., Brandt S., Anton M., et al. Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria. Pharm. Res. 2012, 29:1344-1365.
141. Nam H.Y., Kwon S.M., Chung H., Lee S.Y., Kwon S.H., Jeon H., et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J. Control. Release 2009, 135:259-267.
142. Nangia S., Sureshkumar R. Effects of nanoparticle charge and shape anisotropy on translocation through cell membranes. Langmuir 2012, 28:17666-17671.
143. Narayanan K., Yen S.K., Dou Q., Padmanabhan P., Sudhaharan T., Ahmed S., et al. Mimicking cellular transport mechanism in stem cells through endosomal escape of new peptide-coated quantum dots. Sci. Rep. 2013, 3:2184. 10.1038/srep02184.
144. Nativo P., Prior I.A., Brust M. Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2008, 2:1639-1644.
145. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M.V., Somasundaran P., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557.
146. Nikolic M.S., Krack M., Aleksandrovic V., Kornowski A., Forster S., Weller H. Tailor-made ligands for biocompatible nanoparticles. Angew. Chem. Int. Ed. 2006, 45:6577-6580.
147. Ojea-Jiménez I., García-Fernández L., Lorenzo J., Puntes V.F. Facile preparation of cationic gold nanoparticle-bioconjugates for cell penetration and nuclear targeting. ACS Nano 2012, 6:7692-7702.
148. Ojea-Jiménez I., Tort O., Lorenzo J., Puntes V.F. Engineered nonviral nanocarriers for intracellular gene delivery applications. Biomed. Mater. 2012, 7:054106.
149. O'Neal D.P., Hirsch L.R., Halas N.J., Payne J.D., West J.L. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004, 209:171-176.
150. Pan Y., Neuss S., Leifert A., Fischler M., Wen F., Simon U., et al. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3:1941-1949.
151. Pantarotto D., Briand J.P., Prato M., Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. 2004, 16-17.
152. Pantarotto D., Singh R., McCarthy D., Erhardt M., Briand J.P., Prato M., et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew. Chem. Int. Ed. 2004, 43:5242-5246.
153. Parak W.J. Complex colloidal assembly. Science 2011, 334:1359-1360.
154. Parak W.J., Boudreau R., Gros M.L., Gerion D., Zanchet D., Micheel C.M., et al. Cell motility and metastatic potential studies based on quantum dot imaging of phagokinetic tracks. Adv. Mater. 2002, 14:882-885.
155. Park E.-J., Park K. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol. Lett. 2009, 184:18-25.
156. Parton R.G., Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 2007, 8:185-194.
157. Pelaz B., Charron G., Pfeiffer C., Zhao Y., de la Fuente J.M., Liang X.-J., et al. Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions. Small 2013, 9:1573-1584.
158. Perrault S.D., Chan W.C.W. Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50-200nm. J. Am. Chem. Soc. 2009, 131:17042-17043.
159. Peteiro-Cartelle J., Rodríguez-Pedreira M., Zhang F., Rivera_Gil P., del_Mercato L.L., Parak W.J. One example on how colloidal nano- and microparticles could contribute to medicine. Nanomedicine 2009, 4:967-979.
160. Pinaud F., King D., Moore H.-P., Weiss S. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J. Am. Chem. Soc. 2004, 126:6115-6123.
161. Qiu Y., Liu Y., Wang L.M., Xu L.G., Bai R., Ji Y.L., et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010, 31:7606-7619.
162. Rauch J., Kolch W., Mahmoudi M. Cell type-specific activation of AKT and ERK signaling pathways by small negatively-charged magnetic nanoparticles. Sci. Rep. 2012, 2:868.
163. Rauch J., Kolch W., Laurent S., Mahmoudi M. Big signals from small particles: regulation of cell signaling pathways by nanoparticles. Chem. Rev. 2013, 113:3391-3406.
164. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 2004, 377:159-169.
165. Reynwar B.J., Illya G., Harmandaris V.A., Muller M.M., Kremer K., Deserno M. Aggregation and vesiculation of membrane proteins by curvature-mediated interactions. Nature 2007, 447:461-464.
166. Rivera-Gil P., Parak W.J. Composite nanoparticles take aim at cancer. ACS Nano 2008, 2:2200-2205.
167. Rivera-Gil P., Oberdörster G., Elder A., Puntes V., Parak W.J. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano 2010, 4:5527-5531.
168. Rivera-Gil P., Jimenez De Aberasturi D., Wulf V., Pelaz B., Del Pino P., Zhao Y., et al. The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity. Acc. Chem. Res. 2013, 46:743-9.
169. Rodriguez-Lorenzo L., Krpetic Z., Barbosa S., Alvarez-Puebla R.A., Liz-Marzan L.M., Prior I.A., et al. Intracellular mapping with SERS-encoded gold nanostars. Integr. Biol. 2011, 3:922-926.
170. Rothen-Rutishauser B.M., Schürch S., Haenni B., Kapp N., Gehr P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Technol. 2006, 40:4353-4359.
171. Ruoslahti E., Bhatia S.N., Sailor M.J. Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 2010, 188:759-768.
172. Safi M., Courtois J., Seigneuret M., Conjeaud H., Berret J.F. The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 2011, 32:9353-9363.
173. Salvati A., Pitek A.S., Monopoli M.P., Prapainop K., Bombelli F.B., Hristov D.R., et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 2013, 8:137-143.
174. Sau T.K., Rogach A.L. Nonspherical noble metal nanoparticles: colloid-chemical synthesis and morphology control. Adv. Mater. 2010, 22:1781-1804.
175. Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Kruger A., et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 2002, 9:102-109.
176. Schweiger C., Hartmann R., Zhang F., Parak W., Kissel T., Rivera_Gil P. Quantification of the internalization patterns of superparamagnetic iron oxide nanoparticles with opposite charge. J. Nanotechnol. 2012, 10:28.
177. Sée V., Free P., Cesbron Y., Nativo P., Shaheen U., Rigden D., et al. Cathepsin L digestion of nanobioconjugates upon endocytosis. ACS Nano 2009, 3:2461-2468.
178. Selvan S.T., Patra P.K., Ang C.Y., Ying J.Y. Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angew. Chem. Int. Ed. 2007, 46:2448-2452.
179. Selvan S.T., Tan T.T.Y., Yi D.K., Jana N.R. Functional and multifunctional nanoparticles for bioimaging and biosensing. Langmuir 2010, 26:11631-11641.
180. Shi Kam N.W., Jessop T.C., Wender P.A., Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 2004, 126:6850-6851.
181. Shi X., von Dem Bussche A., Hurt R.H., Kane A.B., Gao H. Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat. Nanotechnol. 2011, 6:714-719.
182. Singhal R., Orynbayeva Z., Sundaram R.V.K., Niu J.J., Bhattacharyya S., Vitol E.A., et al. Multifunctional carbon-nanotube cellular endoscopes. Nat. Nanotechnol. 2011, 6:57-64.
183. Smith K.A., Jasnow D., Balazs A.C. Designing synthetic vesicles that engulf nanoscopic particles. J. Chem. Phys. 2007, 127:084703.
184. Smith A.M., Mancini M.C., Nie S.M. Bioimaging: second window for in vivo imaging. Nat. Nanotechnol. 2009, 4:710-711.
185. Soenen S.J.H., Brisson A.R., Jonckheere E., Nuytten N., Tan S., Himmelreich U., et al. The labeling of cationic iron oxide nanoparticle-resistant hepatocellular carcinoma cells using targeted magnetoliposomes. Biomaterials 2011, 32:1748-1758.
186. Soenen S.J., Manshian B., Montenegro J.M., Amin F., Meermann B., Thiron T., et al. Cytotoxic effects of gold nanoparticles: a multiparametric study. ACS Nano 2012, 6:5767-5783.
187. Sood A., Salih S., Roh D., Lacharme-Lora L., Parry M., Hardiman B., et al. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nat. Nanotechnol. 2011, 6:824-833.
188. Suri S.S., Fenniri H., Singh B. Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2007, 2:16.
189. Suzuki R., Oda Y., Utoguchi N., Maruyama K. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles. J. Control. Release 2011, 149:36-41.
190. Tanguay R.L., Harper S.L., Carriere J.L., Miller J.M., Hutchison J.E., Maddux B.L.S. Systematic evaluation of nanomaterial toxicity: utility of standardized materials and rapid assays. ACS Nano 2011, 5:4688-4697.
191. Tekle C., van Deurs B., Sandvig K., Iversen T.G. Cellular trafficking of quantum dot-ligand bioconjugates and their induction of changes in normal routing of unconjugated ligands. Nano Lett. 2008, 8:1858-1865.
192. Tenzer S., Docter D., Rosfa S., Wlodarski A., Kuharev J., Rekik A., et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 2011, 5:7155-7167.
193. Ulbrich K., Hekmatara T., Herbert E., Kreuter J. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur. J. Pharm. Biopharm. 2009, 71:251-256.
194. van Meer G., Voelker D.R., Feigenson G.W. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 2008, 9:112-124.
195. Veiseh O., Kievit F.M., Mok H., Ayesh J., Clark C., Fang C., et al. Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. Biomaterials 2011, 32:5717-5725.
196. Verma A., Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
197. Verma A., Uzun O., Hu Y., Hu Y., Han H.-S., Watson N., et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat. Mater. 2008, 7:588-595.
198. Wagner E. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise. Acc. Chem. Res. 2012, 45:1005-1013.
199. Walkey C.D., Chan W.C.W. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 2012, 41:2780-2799.
200. Walkey C.D., Olsen J.B., Guo H., Emili A., Chan W.C.W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 2012, 134:2139-2147.
201. Wang T., Bai J., Jiang X., Nienhaus G.U. Cellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistry. ACS Nano 2012, 6:1251-1259.
202. Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gellermann J., Riess H., et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002, 3:487-497.
203. Xia Y.N., Halas N.J. Shape-controlled synthesis and surface plasmonic properties of metallic nanostructures. MRS Bull. 2005, 30:338-344.
204. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6:1794-1807.
205. Xia T., Kovochich M., Liong M., Meng H., Kabehie S., George S., et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 2009, 3:3273-3286.
206. Xu J., Teslaa T., Wu T.-H., Chiou P.-Y., Teitell M.A., Weiss S. Nanoblade delivery and incorporation of quantum dot conjugates into tubulin networks in live cells. Nano Lett. 2012, 12:5669-5672.
207. Yang K., Ma Y.-Q. Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat. Nanotechnol. 2010, 5:579.
208. Yang P.-H., Sun X., Chiu J.-F., Sun H., He Q.-Y. Transferrin-mediated gold nanoparticle cellular uptake. Bioconjug. Chem. 2005, 16:494-496.
209. Yang H., Liu C., Yang D., Zhang H., Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol. 2009, 29:69-78.
210. Yen S.K., Jańczewski D., Lakshmi J.L., Dolmanan S.B., Tripathy S., Ho V.H.B., et al. Design and synthesis of polymer-functionalized NIR fluorescent dyes-magnetic nanoparticles for bioimaging. ACS Nano 2013, 7:6796-6805.
211. Yoo H.S., Park T.G. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Control. Release 2004, 100:247-256.
212. Yoo J.W., Irvine D.J., Discher D.E., Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 2011, 10:521-535.
213. Yuan H., Fales A.M., Vo-Dinh T. TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. J. Am. Chem. Soc. 2012, 134:11358-11361.
214. Zhang S., Li J., Lykotrafitis G., Bao G., Suresh S. Size-dependent endocytosis of nanoparticles. Adv. Mater. 2009, 21:419-424.
215. Zhang F., Lees E., Amin F., Rivera-Gil P., Yang F., Mulvaney P., et al. Polymer-coated nanoparticles: a universal tool for biolabelling experiments. Small 2011, 7:3113-3127.
216. Zhang F., Braun G.B., Pallaoro A., Zhang Y., Shi Y., Cui D., et al. Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. Nano Lett. 2011, 12:61-67.
217. Zhang L., Cao Z., Li Y., Ella-Menye J.-R., Bai T., Jiang S. Softer zwitterionic nanogels for longer circulation and lower splenic accumulation. ACS Nano 2012, 6:6681-6686.
218. Zhang X., Servos M.R., Liu J. Ultrahigh nanoparticle stability against salt, pH, and solvent with retained surface accessibility via depletion stabilization. J. Am. Chem. Soc. 2012, 134:9910-9913.
219. Zhao F., Zhao Y., Liu Y., Chang X., Chen C., Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 2011, 7:1322-1337.